Savara
SVRA
#6165
Rank
A$1.54 B
Marketcap
A$7.54
Share price
-1.11%
Change (1 day)
38.53%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -A$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.17 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.2 Billion15.48%
2025 -A$0.17 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$76.9 Million43.38%
2022 -A$53.64 Million-11.31%
2021 -A$60.48 Million-13.3%
2020 -A$69.76 Million-36.53%
2019 -A$0.11 Billion13.76%
2018 -A$96.61 Million105.54%
2017 -A$47.01 Million34.11%
2016 -A$35.05 Million-37.43%
2015 -A$56.02 Million38.81%
2014 -A$40.36 Million33.62%
2013 -A$30.2 Million38.49%
2012 -A$21.81 Million24.59%
2011 -A$17.51 Million-36.5%
2010 -A$27.57 Million-3.14%
2009 -A$28.46 Million-23.28%
2008 -A$37.1 Million8.52%
2007 -A$34.18 Million-34.14%
2006 -A$51.9 Million184.43%
2005 -A$18.25 Million90.75%
2004 -A$9.57 Million190.35%
2003 -A$3.3 Million11.64%
2002 -A$2.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.33 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.53 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA